AOD9604

"Our metabolic research lab at a clinical research team in Chandigarh has been using LyzeLabs AOD9604 for selective lipolysis studies for 10 months. The pharmaceutical quality is exceptional - we independently verified >98.7% purity via HPLC and mass spec confirmed the modified GH fragment with N-terminal tyrosine (molecular weight 1847.3 Da matching theoretical). Our research investigates AOD9604's GHR-independent fat metabolism - differentiated 3T3-L1 adipocyte bioassays show robust dose-dependent glycerol and free fatty acid release (colorimetric/ELISA quantification) with EC50 ~0.4 µM, confirming potent lipolytic activity. We validated GHR non-activation using GHR-expressing cells - AOD9604 produces zero STAT5 phosphorylation (Western blot) vs full hGH's strong pSTAT5 signal, demonstrating selective mechanism. Lipase activation assays show AOD9604 induces HSL Ser660 phosphorylation and ATGL activation comparable to β3-adrenergic agonists, validating triglyceride hydrolysis mechanism. The critical advantage is selective lipolysis without hGH's hyperglycemic effects - glucose tolerance tests in rodent obesity models show AOD9604 reduces fat mass without impairing insulin sensitivity (unlike full hGH which antagonizes insulin). We measured enhanced fatty acid β-oxidation (Seahorse analysis) confirming AOD9604 shifts metabolism toward lipid utilization. The 2AD and 5AD specifications support our dose-response and chronic obesity protocols perfectly. Delivery to Punjab takes 11-13 days with cold-chain packaging. Premier selective lipolytic peptide for international metabolic research."

2025-11-16

"Repeatable quality. That matters more than any one good order."

2025-11-13

"HPLC read lined up with the posted COA. Reordered."

2025-11-10